Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas
Clinical trial NCT01670890 · UNKNOWN
Trial details
- NCT number
- NCT01670890
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.